March 6, 2019

PET Monitoring Can Be Used to Tailor Hodgkin’s Treatment, Trial Suggests

Monitoring Hodgkin’s lymphoma patients with positron-emission tomography (PET) scans during chemotherapy can help identify those who respond early to a more intense chemotherapy regimen and switch them to a softer, less toxic regimen, helping to avoid adverse side effects while maintaining the same chance of successful treatment, a Phase 3 trial shows. {read more here}